Executive Search · Life Sciences
Specialist recruitment for biotech and pharmaceutical executives across all therapeutic areas. C-suite search for drug development companies from startup to IPO. Connect with experienced life sciences leaders who build pipelines, navigate regulatory pathways, and scale biotech companies.
Define therapeutic focus, development stage, regulatory pathway, and leadership requirements. Assess company stage, pipeline, and investor backing.
Target executives with relevant therapeutic area experience, regulatory expertise, and track record in similar development stages and company sizes.
Comprehensive evaluation including scientific publications, drug development track record, regulatory submission history, and board/investor references.
Pipeline assessment, regulatory strategy review, competitive landscape analysis, and commercial potential evaluation with selected candidates.
Offer negotiation including equity components, clinical milestone bonuses, and regulatory success incentives. Integration with board and key investors.
Oncology: Cancer drug development executives, immuno-oncology leadership, cell and gene therapy experts, clinical trial design specialists for complex oncology programs.
Rare Diseases: Orphan drug development leadership, regulatory strategy for rare disease pathways, patient advocacy experience, ultra-rare disease commercial expertise.
CNS & Neurology: Neuroscience drug development, CNS clinical trial expertise, neurological biomarker development, brain-blood barrier delivery system experience.
Immunology & Inflammation: Autoimmune disease programs, inflammation pathway expertise, biologic drug development, immunology clinical development leadership.
Cell & Gene Therapy: CGT manufacturing expertise, viral vector development, CAR-T programs, gene editing platforms, advanced therapy commercialisation.
Early-stage biotech: Seed and Series A companies building initial teams, establishing scientific advisory boards, and recruiting founding leadership with drug development expertise.
Clinical-stage companies: Series B-C companies advancing to clinical trials, requiring regulatory affairs leadership, clinical development executives, and commercial strategy teams.
Late-stage biotech: Pre-IPO companies preparing for market launch, requiring commercial leadership, market access executives, and manufacturing scale-up expertise.
Public biotech companies: Listed companies requiring board-level executives, investor relations leadership, and public company governance expertise in life sciences.
Book a consultation to discuss your life sciences leadership requirements.
Book Biotech Search Call →"Biotech executive demand surges 67% as UK life sciences sector attracts record investment and talent competition intensifies."
"Association of the British Pharmaceutical Industry analysis showing critical shortage of experienced biotech leadership."
"Comprehensive analysis of C-suite compensation trends across UK biotech sector from startup to public companies."
"Analysis of biotech leadership recruitment trends, compensation benchmarks, and market dynamics across development stages."
